CTOs on the Move

Unicare Health of Texas

www.unicare.com

 
Unicare Health of Texas is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.unicare.com
  • 11200 Westheimer Rd Ste 700
    Houston, TX USA 77042
  • Phone: 800.679.1868

Executives

Name Title Contact Details

Similar Companies

ISS Solutions

ISS Solutions is a Langhorne, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Toby Orthopaedics

Toby Orthopaedics is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mental Health Centers of Western Illinois

Mental Health Centers of Western Illinois is a Pittsfield, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Memorial Hospital and Health Care Center

Memorial Hospital and Health Care Center offers a comprehensive range of acute medical services in a 137-bed facility located on Ninth Street in Jasper. As a regional health center with approximately 100 active staff physicians and 1,700 employees, Memorial Hospital serves Dubois and surrounding counties in southern Indiana. Under the sponsorship of the Sisters of the Little Company of Mary, the hospital annually provides care for 6,600 inpatients and 254,000 outpatients. Mission: Christ`s healing mission of compassion empowers us to be for others through quality and excellence. Core Values: Compassionate Caring, Respect for Human Dignity, Quality, Justice, and Stewardship

FibroGen

FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).